Trial Profile
A Phase II Double-blind and Randomized Trial Comparing Concurrent Chemoradiotherapy Plus PG2 Injection Versus Concurrent Chemoradiotherapy Plus Placebo in Advanced Pharyngeal or Laryngeal Squamous Cell Carcinoma
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs PG 2 (Primary)
- Indications Fatigue
- Focus Therapeutic Use
- Sponsors PhytoHealth
- 01 Jan 2020 Results published in the Journal of Cancer Research and Clinical Oncology
- 03 Nov 2015 Status changed from recruiting to discontinued, according to ClinicalTrials.gov record.
- 29 Apr 2015 New trial record